Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-09-24 Purchase |
2020-09-28 07:48 am |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
8,000 | $2.13 | $17,040 | 74,896 (Direct) |
View |
2020-09-17 Purchase |
2020-09-21 9:48 pm |
Strongbridge Biopharma plc | SBBP | CDK ASSOCIATES L.L.C. CAXTON CORP Kovner Bruce 10% Owner |
1,479,377 | $2.2498 | $3,328,298 | 8,060,682 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-07 Option Award |
2021-01-08 08:37 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Wilhoit Scott L. Chief Commercial Officer |
113,000 | $0 | 144,146 (Direct) |
View |
2021-01-07 Option Award |
2021-01-08 08:35 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Lutz Robert Matthew Chief Financial Officer |
147,500 | $0 | 188,311 (Direct) |
View |
2021-01-07 Option Award |
2021-01-08 08:35 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | LONG STEPHEN J Chief Legal Officer |
143,500 | $0 | 174,162 (Direct) |
View |
2021-01-07 Option Award |
2021-01-08 08:34 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Kollender Richard S Chief Operating Officer |
147,500 | $0 | 247,500 (Direct) |
View |
2021-01-07 Option Award |
2021-01-08 08:33 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Cohen Fredric J. Chief Medical Officer |
181,000 | $0 | 218,934 (Direct) |
View |
2021-01-07 Option Award |
2021-01-08 08:33 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
491,000 | $0 | 1,013,152 (Direct) |
View |
2020-09-03 Tax Withholding |
2020-09-04 4:28 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
23,104 | $3.61 | 66,896 (Direct) |
View |
2020-07-02 Option Award |
2020-07-07 08:11 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
315,000 | $0 | 522,152 (Direct) |
View |
2020-05-15 Tax Withholding |
2020-05-18 4:52 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Steineger Hilde H Director |
19,035 | $2.86 | 60,965 (Direct) |
View |
2020-05-15 Tax Withholding |
2020-05-18 4:52 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Steen Marten Director |
19,082 | $2.86 | 60,918 (Indirect) |
View |
2020-05-15 Tax Withholding |
2020-05-18 4:51 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | SHERMAN JEFFREY W Director |
19,035 | $2.86 | 60,965 (Direct) |
View |
2020-05-15 Tax Withholding |
2020-05-18 4:51 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Kong Garheng Director |
19,044 | $2.86 | 60,956 (Direct) |
View |
2020-05-15 Tax Withholding |
2020-05-18 4:51 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Executive Chairman |
15,348 | $2.86 | 207,152 (Direct) |
View |
2020-05-14 Option Award |
2020-05-15 5:28 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Kong Garheng Director |
40,000 | $0 | 80,000 (Direct) |
View |
2020-05-14 Option Award |
2020-05-15 5:10 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | SHERMAN JEFFREY W Director |
40,000 | $0 | 80,000 (Direct) |
View |
2020-05-14 Option Award |
2020-05-15 5:03 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Steineger Hilde H Director |
40,000 | $0 | 80,000 (Direct) |
View |
2020-05-14 Option Award |
2020-05-15 4:47 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
40,000 | $0 | 90,000 (Direct) |
View |
2020-05-14 Option Award |
2020-05-15 4:46 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | Steen Marten Director |
40,000 | $0 | 80,000 (Indirect) |
View |